We reassessed the effect of cytoreductive nephrectomy on survival in a population-based contemporary clear-cell metastatic renal cell carcinoma (ccmRCC) cohort. Our analyses demonstrated that cytoreductive nephrectomy improves survival of patients with clear-cell metastatic renal cell carcinoma, including those exposed to targeted therapy.
Contemporary Cytoreductive Nephrectomy Provides Survival Benefit in Clear-cell Metastatic Renal Cell Carcinoma
Briganti A.;
2020-01-01
Abstract
We reassessed the effect of cytoreductive nephrectomy on survival in a population-based contemporary clear-cell metastatic renal cell carcinoma (ccmRCC) cohort. Our analyses demonstrated that cytoreductive nephrectomy improves survival of patients with clear-cell metastatic renal cell carcinoma, including those exposed to targeted therapy.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
